GENDER-RELATED CHARACTERISTICS OF PATIENTS WITH TRANSIENT ISCHEMIC ATTACKS
N. Khodjayeva , N. Aliyeva ,Abstract
This article analyzes the clinical and neurological features of transient ischemic attacks (TIA). The study results reveal TIA risk factors and their role in stroke development. Key patient characteristics and diagnostic methods are highlighted.
Keywords
transient ischemic attack, cerebrovascular reactivity, stroke, risk factors, diagnostics.
References
World Health Organization. Global Health Estimates 2020. WHO, Geneva; 2021.
Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063-1072.
Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40(6):2276-2293.
AHA/ASA Stroke Council. Guidelines for the management of patients with transient ischemic attack. Stroke. 2019;50(12).
Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215-225.
Rakhimbaeva G.S., Mirkhaetova N.A. Clinical and neurological characteristics of patients with chronic cerebral ischemia against the background of the combined course of hypertension and atherosclerosis depending on the course stage //»Development and innovations in science», International scientific-online conference, Netherlands
Rothwell PM, Giles MF, Flossmann E, et al. A simple score (ABCD²) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366(9479):29-36.
Elkind MSV. Inflammatory mechanisms of stroke. Stroke. 2010;41(10 Suppl).
Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478-2486.
Hankey GJ. Secondary stroke prevention. Lancet Neurol. 2014;13(2):178-194.
Article Statistics
Copyright License
Copyright (c) 2024 N. Khodjayeva, N. Aliyeva
This work is licensed under a Creative Commons Attribution 4.0 International License.